The role of multiparametric MRI in biopsy-naive prostate cancer

被引：0

作者：

Amir H. Lebastchi

Peter A. Pinto

机构：

[1] Urologic Oncology Branch,

[2] National Cancer Institute,undefined

[3] National Institutes of Health,undefined

来源：

Nature Reviews Urology | 2019年 / 16卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Results of recent trials have shown the superiority of mpMRI to TRUS-guided systematic biopsy for detecting clinically significant prostate cancer. However, only performing an mpMRI risks missing MRI-invisible lesions and, therefore, there might be added value in performing both targeted and systematic biopsies in biopsy-naive patients.

引用

页码：276 / 277

页数：1

共 50 条

[21] Detection of clinically significant prostate cancer in biopsy-naive men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy
Mannaerts, Christophe K. as
Engelbrecht, Marc R. W.
Postema, Arnoud W.
Kollenburg, Rob A. A.
Hoeks, Caroline M. A.
Savci-Heijink, Cemile Dilara
Van Sloun, Ruud J. G.
Wildeboer, Rogier R.
De Reijke, Theo M.
Mischi, Massimo
Wijkstra, Hessel
BJU INTERNATIONAL, 2020, 126 (04) : 481 - 493
[22] Micro-ultrasound for the detection of clinically significant prostate cancer in biopsy-naive men with negative MRI
Albers, Patrick
Bennett, Jacob
Evans, Moira
Martin, Ella St.
Wang, Betty
Broomfield, Stacey
Martin, Anais Medina
Tu, Wendy
Fung, Christopher
Kinnaird, Adam
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2024, 18 (06): : 208 - 211
[23] Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naive Patients in the Detection of Clinically Significant Prostate Cancer
Barone, Biagio
Napolitano, Luigi
Calace, Francesco Paolo
Del Biondo, Dario
Napodano, Giorgio
Grillo, Marco
Reccia, Pasquale
De Luca, Luigi
Prezioso, Domenico
Muto, Matteo
Crocetto, Felice
Ferro, Matteo
DIAGNOSTICS, 2023, 13 (11)
[24] Integration of PSAd and multiparametric MRI to forecast biopsy outcomes in biopsy-naive patients with PSA 4∼20 ng/ml
Ren, Lei
Chen, Yanling
Liu, Zixiong
Huang, Guankai
Wang, Weifeng
Yang, Xu
Bai, Baohua
Guo, Yan
Ling, Jian
Mao, Xiaopeng
FRONTIERS IN ONCOLOGY, 2024, 14
[25] Impact of changing PI-RADS cutoff on prostate cancer detection by MRI cognitive fusion biopsy in biopsy-naive patients
El-Helaly, Hesham Abdel-Azim
Mahmoud, Asem Abdel-Aziz
Magdy, Ahmed Mohamed
Hasehem, Abdelwahab
Ibrahim, Hamdy Mohamed
Mohamed, Khaled Moheyelden
Ismail, Mohamed Hamdy
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2023, 35 (01)
[26] Prostate Cancer: Targeted Fusion Biopsy with multiparametric MRI
von Hardenberg, Jost
Westhoff, Niklas
AKTUELLE UROLOGIE, 2019, 50 (05) : 473 - 474
[27] ROLE OF PREBIOPSY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING FOR PROSTATE CANCER DIAGNOSIS IN BIOPSY-NAIVE MEN: A LITERATURE BASED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Tu, Xiang
Qiu, Shi
Xu, He
Bao, Yige
Yang, Lu
Wei, Qiang
JOURNAL OF UROLOGY, 2019, 201 (04): : E422 - E422
[28] Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10ng/mL
Dwivedi, Durgesh Kumar
Kumar, Rajeev
Dwivedi, Alok Kumar
Bora, Girdhar S.
Thulkar, Sanjay
Sharma, Sanjay
Gupta, Siddhartha Datta
Jagannathan, Naranamangalam R.
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 47 (05) : 1227 - 1236
[29] Choosing the Right Diagnostic Pathway in Biopsy-Naive Patients With Suspected Prostate Cancer
Rouviere, Olivier
JAMA ONCOLOGY, 2021, 7 (04) : 542 - 543
[30] Predictors of clinically significant prostate cancer in biopsy-naive and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator
van Riel, Luigi A. M. J. G.
Jager, Auke
Meijer, Dennie
Postema, Arnoud W.
Smit, Ruth S.
Vis, Andre N.
de Reijke, Theo M.
Beerlage, Harrie P.
Oddens, Jorg R.
THERAPEUTIC ADVANCES IN UROLOGY, 2022, 14

← 1 2 3 4 5 →